963 reports of this reaction
5.1% of all ICOSAPENT ETHYL reports
#1 most reported adverse reaction
PRODUCT ODOUR ABNORMAL is the #1 most commonly reported adverse reaction for ICOSAPENT ETHYL, manufactured by Amarin Pharma Inc.. There are 963 FDA adverse event reports linking ICOSAPENT ETHYL to PRODUCT ODOUR ABNORMAL. This represents approximately 5.1% of all 18,725 adverse event reports for this drug.
Patients taking ICOSAPENT ETHYL who experience product odour abnormal should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRODUCT ODOUR ABNORMAL is moderately reported among ICOSAPENT ETHYL users, representing a notable but not dominant share of adverse events.
In addition to product odour abnormal, the following adverse reactions have been reported for ICOSAPENT ETHYL:
The following drugs have also been linked to product odour abnormal in FDA adverse event reports:
PRODUCT ODOUR ABNORMAL has been reported as an adverse event in 963 FDA reports for ICOSAPENT ETHYL. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRODUCT ODOUR ABNORMAL accounts for approximately 5.1% of all adverse event reports for ICOSAPENT ETHYL, making it one of the most commonly reported side effect.
If you experience product odour abnormal while taking ICOSAPENT ETHYL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.